These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15163713)

  • 1. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
    Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
    J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles.
    Murakami P; Pungor E; Files J; Do L; van Rijnsoever R; Vogels R; Bout A; McCaman M
    Hum Gene Ther; 2002 May; 13(8):909-20. PubMed ID: 12031124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
    Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H
    Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells.
    Marzio G; Kerkvliet E; Bogaards JA; Koelewijn S; De Groot A; Gijsbers L; Weverling GJ; Vogels R; Havenga M; Custers J; Pau MG; Guichoux JY; Lewis J; Goudsmit J
    Vaccine; 2007 Mar; 25(12):2228-37. PubMed ID: 17250936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
    Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
    Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a packaging cell line for propagation of replication-deficient adenovirus vector.
    Kim JS; Lee SH; Cho YS; Park K; Kim YH; Lee JH
    Exp Mol Med; 2001 Sep; 33(3):145-9. PubMed ID: 11642550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
    Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
    Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC
    J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human adenovirus type 35: nucleotide sequence and vector development.
    Gao W; Robbins PD; Gambotto A
    Gene Ther; 2003 Nov; 10(23):1941-9. PubMed ID: 14528318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors.
    Gonçalves MA; Pau MG; de Vries AA; Valerio D
    Virology; 2001 Sep; 288(2):236-46. PubMed ID: 11601895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
    Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
    Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
    Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
    Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of helper-dependent adenovirus vector relies on helper virus structure and complementing.
    Zhou HS; Zhao T; Rao XM; Beaudet AL
    J Gene Med; 2002; 4(5):498-509. PubMed ID: 12221643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes.
    Marienfeld U; Haack A; Thalheimer P; Schneider-Rasp S; Brackmann HH; Poller W
    Gene Ther; 1999 Jun; 6(6):1101-13. PubMed ID: 10455413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing E1 deleted adenoviral vector by homologous recombination.
    Zamani A; Ghannad MS
    Iran Biomed J; 2007 Jul; 11(3):199-202. PubMed ID: 18051781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations.
    Alemany R; Dai Y; Lou YC; Sethi E; Prokopenko E; Josephs SF; Zhang WW
    J Virol Methods; 1997 Nov; 68(2):147-59. PubMed ID: 9389404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.
    Fallaux FJ; Kranenburg O; Cramer SJ; Houweling A; Van Ormondt H; Hoeben RC; Van Der Eb AJ
    Hum Gene Ther; 1996 Jan; 7(2):215-22. PubMed ID: 8788172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.
    Torrent C; Jullien C; Klatzmann D; Perricaudet M; Yeh P
    Cancer Gene Ther; 2000 Aug; 7(8):1135-44. PubMed ID: 10975674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.
    Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A
    J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.